Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12590136 | Engineered T cells | 🖼🧊📄§ | 2026-03-31 | 2040-05-07 | 0 | 31 |
| 12589123 | Compositions and methods comprising clostridium butyricum for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-04-20 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589099 | Alpha-1062 for treating traumatic brain injury | 🖼🧊📄§ | 2026-03-31 | 2042-11-25 | 0 | 31 |
| 12589071 | Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof | 🖼🧊📄§ | 2026-03-31 | 2044-02-26 | 0 | 31 |
| 12589133 | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12589118 | Method of prolonging the lifespan of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) using a cerebrolysin® preparation | 🖼🧊📄§ | 2026-03-31 | 2038-08-28 | 0 | 31 |
| 12590098 | Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-03-31 | 2041-09-15 | 0 | 31 |
| 12590146 | CLDN18.2-targeting antibody, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-09-29 | 0 | 31 |
| 12590169 | 5T4 single domain antibodies and therapeutic compositions thereof | 🖼🧊📄§ | 2026-03-31 | 2039-10-09 | 0 | 31 |
| 12589093 | Plasma kallikrein inhibitors and methods of use thereof in ocular disorders | 🖼🧊📄§ | 2026-03-31 | 2040-04-08 | 0 | 31 |
| 12588675 | Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms | 🖼🧊📄§ | 2026-03-31 | 2043-04-03 | 0 | 31 |
| 12589078 | Lipid nanoparticles for delivery of nucleic acids | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589125 | Yogurt for regulating intestinal tract, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12589069 | Ophthalmic suspension composition | 🖼🧊📄§ | 2026-03-31 | 2042-12-21 | 0 | 31 |
| 12589087 | Enantiomer selective action on neurotransmission | 🖼🧊📄§ | 2026-03-31 | 2042-04-01 | 0 | 31 |
| 12589109 | Therapy to stimulate hippocampal neural progenitors and adult neurogenesis | 🖼🧊📄§ | 2026-03-31 | 2041-09-03 | 0 | 31 |
| 12589088 | Compositions and methods for treating cancer with andrographolide and melatonin combination therapy | 🖼🧊📄§ | 2026-03-31 | 2041-04-30 | 0 | 31 |
| 12590165 | Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B | 🖼🧊📄§ | 2026-03-31 | 2041-03-05 | 0 | 31 |
| 12588679 | Systems, methods, and apparatuses for disinfection and decontamination | 🖼🧊📄§ | 2026-03-31 | 2043-03-21 | 0 | 31 |
| 12589157 | Compositions of drug delivery agents and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12590063 | Phenol derivative | 🖼🧊📄§ | 2026-03-31 | 2041-09-03 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12589144 | Combined norovirus and rotavirus vaccine composition and methods of preparation | 🖼🧊📄§ | 2026-03-31 | 2041-01-06 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12590145 | Bi-specific chimeric antigen receptor | 🖼🧊📄§ | 2026-03-31 | 2041-05-18 | 0 | 31 |
| 12589097 | Apilimod compositions and methods of use | 🖼🧊📄§ | 2026-03-31 | 2043-08-03 | 0 | 31 |
| 12589094 | Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 | 🖼🧊📄§ | 2026-03-31 | 2044-02-28 | 0 | 31 |
| 12589124 | Bifidobacterium longum | 🖼🧊📄§ | 2026-03-31 | 2041-03-12 | 0 | 31 |
| 12589112 | Oncolytic virus compositions including IL-15 complex and methods for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-01-22 | 0 | 31 |
| 12589166 | Compositions and methods for treating wounds | 🖼🧊📄§ | 2026-03-31 | 2041-05-13 | 0 | 31 |
| 12589164 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2045-03-14 | 0 | 31 |
| 12589149 | Method of modulating mucosal immunogenicity | 🖼🧊📄§ | 2026-03-31 | 2040-03-18 | 0 | 31 |
| 12589103 | Antimicrobial and antiviral effects of C2-C7 alkyl boronic acids | 🖼🧊📄§ | 2026-03-31 | 2040-10-07 | 0 | 31 |
| 12590295 | Mesenchymal stromal cells as a reprogramming source for iPSC induction | 🖼🧊📄§ | 2026-03-31 | 2040-11-27 | 0 | 31 |
| 12590100 | Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease | 🖼🧊📄§ | 2026-03-31 | 2042-01-13 | 0 | 31 |
| 12582617 | Methods for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-29 | 0 | 31 |
| 12584146 | Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines | 🖼🧊📄§ | 2026-03-24 | 2045-04-18 | 0 | 31 |
| 12583915 | Methods for diagnosing cancer using anti-BAG2 antibody | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12582714 | Methods and compositions for freezing and thawing mammalian cells | 🖼🧊📄§ | 2026-03-24 | 2043-07-28 | 0 | 31 |
| 12582668 | Methods for the treatment of alpha-1 antitrypsin deficiency (AATD) | 🖼🧊📄§ | 2026-03-24 | 2040-06-05 | 0 | 31 |
| 12583900 | Peptide conjugates and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-12-03 | 0 | 31 |
| 12582708 | Recombinant influenza viruses comprising truncated NS1 fusion proteins | 🖼🧊📄§ | 2026-03-24 | 2040-02-10 | 0 | 31 |
| 12583894 | Materials and methods for the treatment of Lewy body disorders | 🖼🧊📄§ | 2026-03-24 | 2039-04-03 | 0 | 31 |
| 12582679 | Compositions and methods for the treatment of allergy | 🖼🧊📄§ | 2026-03-24 | 2041-04-19 | 0 | 31 |
| 12582725 | AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease | 🖼🧊📄§ | 2026-03-24 | 2040-06-03 | 0 | 31 |
| 12582619 | Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections | 🖼🧊📄§ | 2026-03-24 | 2041-03-30 | 0 | 31 |
| 12583845 | Compositions and methods for treating diseases, disorders and conditions involving trinucleotide repeats | 🖼🧊📄§ | 2026-03-24 | 2042-10-04 | 0 | 31 |
| 12582705 | Composition comprising botulinum toxin or salt thereof for increasing endometrial blood flow rate | 🖼🧊📄§ | 2026-03-24 | 2040-04-28 | 0 | 31 |
| 12582720 | Compound for preventing or treating lipid metabolism-related diseases | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |